# A Clinical Trial to Evaluate the Safety and Efficacy of Ciprofloxacin in the Treatment of Plague in Humans

> **NCT01243437** · PHASE2 · COMPLETED · sponsor: **Centers for Disease Control and Prevention** · enrollment: 200 (actual)

## Conditions studied

- Plague

## Interventions

- **DRUG:** ciprofloxacin
- **DRUG:** doxyxcycline

## Key facts

- **NCT ID:** NCT01243437
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01243437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01243437, "A Clinical Trial to Evaluate the Safety and Efficacy of Ciprofloxacin in the Treatment of Plague in Humans". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01243437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*